Global Prostate Specific Antigen (PSA) Testing Market Research Report 2026(Status and Outlook)

June 2026 | 159 pages | ID: G3F097AB23BFEN
Bosson Research

Abstracts

The global Prostate Specific Antigen (PSA) Testing market size was estimated at USD 2144.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Prostate Specific Antigen (PSA) Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Prostate Specific Antigen (PSA) Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Prostate Specific Antigen (PSA) Testing market.

Global Prostate Specific Antigen (PSA) Testing Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Cleveland Diagnostics
• Abbott
• Siemens Healthineers
• DiaSorin
• Roche Holding AG
• Beckman Coulter
• Mediwatch(LABORIE)
• Boditech
• Bristol Myers Squibb
• GE Healthcare
• Endocare
• GlaxoSmith Kline
• Anixa Biosciences
• Ortho Clinical
• Fujirebio
• Merck

Market Segmentation (by Type)

• Radioimmunoassay
• Enzyme Immunoassay

Market Segmentation (by Application)

• Hospitals
• Clinics
• Diagnostic Centers
• Research Institute
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Prostate Specific Antigen (PSA) Testing Market

Overview of the regional outlook of the Prostate Specific Antigen (PSA) Testing Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prostate Specific Antigen (PSA) Testing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Prostate Specific Antigen (PSA) Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Prostate Specific Antigen (PSA) Testing
1.2 Key Market Segments
  1.2.1 Prostate Specific Antigen (PSA) Testing Segment by Type
  1.2.2 Prostate Specific Antigen (PSA) Testing Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Prostate Specific Antigen (PSA) Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Prostate Specific Antigen (PSA) Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Prostate Specific Antigen (PSA) Testing Product Life Cycle
3.3 Global Prostate Specific Antigen (PSA) Testing Sales by Manufacturers (2020-2025)
3.4 Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Prostate Specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Prostate Specific Antigen (PSA) Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Prostate Specific Antigen (PSA) Testing Market Competitive Situation and Trends
  3.8.1 Prostate Specific Antigen (PSA) Testing Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Prostate Specific Antigen (PSA) Testing Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PROSTATE SPECIFIC ANTIGEN (PSA) TESTING INDUSTRY CHAIN ANALYSIS

4.1 Prostate Specific Antigen (PSA) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Prostate Specific Antigen (PSA) Testing Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Prostate Specific Antigen (PSA) Testing Market
5.7 ESG Ratings of Leading Companies

6 PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prostate Specific Antigen (PSA) Testing Sales Market Share by Type (2020-2025)
6.3 Global Prostate Specific Antigen (PSA) Testing Market Size by Type (2020-2025)
6.4 Global Prostate Specific Antigen (PSA) Testing Price by Type (2020-2025)

7 PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prostate Specific Antigen (PSA) Testing Market Sales by Application (2020-2025)
7.3 Global Prostate Specific Antigen (PSA) Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Prostate Specific Antigen (PSA) Testing Sales Growth Rate by Application (2020-2025)

8 PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET SALES BY REGION

8.1 Global Prostate Specific Antigen (PSA) Testing Sales by Region
  8.1.1 Global Prostate Specific Antigen (PSA) Testing Sales by Region
  8.1.2 Global Prostate Specific Antigen (PSA) Testing Sales Market Share by Region
8.2 Global Prostate Specific Antigen (PSA) Testing Market Size by Region
  8.2.1 Global Prostate Specific Antigen (PSA) Testing Market Size by Region
  8.2.2 Global Prostate Specific Antigen (PSA) Testing Market Size by Region
8.3 North America
  8.3.1 North America Prostate Specific Antigen (PSA) Testing Sales by Country
  8.3.2 North America Prostate Specific Antigen (PSA) Testing Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Prostate Specific Antigen (PSA) Testing Sales by Country
  8.4.2 Europe Prostate Specific Antigen (PSA) Testing Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Prostate Specific Antigen (PSA) Testing Sales by Region
  8.5.2 Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Prostate Specific Antigen (PSA) Testing Sales by Country
  8.6.2 South America Prostate Specific Antigen (PSA) Testing Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Prostate Specific Antigen (PSA) Testing Sales by Region
  8.7.2 Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET PRODUCTION BY REGION

9.1 Global Production of Prostate Specific Antigen (PSA) Testing by Region(2020-2025)
9.2 Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Region (2020-2025)
9.3 Global Prostate Specific Antigen (PSA) Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Prostate Specific Antigen (PSA) Testing Production
  9.4.1 North America Prostate Specific Antigen (PSA) Testing Production Growth Rate (2020-2025)
  9.4.2 North America Prostate Specific Antigen (PSA) Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Prostate Specific Antigen (PSA) Testing Production
  9.5.1 Europe Prostate Specific Antigen (PSA) Testing Production Growth Rate (2020-2025)
  9.5.2 Europe Prostate Specific Antigen (PSA) Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Prostate Specific Antigen (PSA) Testing Production (2020-2025)
  9.6.1 Japan Prostate Specific Antigen (PSA) Testing Production Growth Rate (2020-2025)
  9.6.2 Japan Prostate Specific Antigen (PSA) Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Prostate Specific Antigen (PSA) Testing Production (2020-2025)
  9.7.1 China Prostate Specific Antigen (PSA) Testing Production Growth Rate (2020-2025)
  9.7.2 China Prostate Specific Antigen (PSA) Testing Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Cleveland Diagnostics
  10.1.1 Cleveland Diagnostics Basic Information
  10.1.2 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product Overview
  10.1.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.1.4 Cleveland Diagnostics Business Overview
  10.1.5 Cleveland Diagnostics SWOT Analysis
  10.1.6 Cleveland Diagnostics Recent Developments
10.2 Abbott
  10.2.1 Abbott Basic Information
  10.2.2 Abbott Prostate Specific Antigen (PSA) Testing Product Overview
  10.2.3 Abbott Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.2.4 Abbott Business Overview
  10.2.5 Abbott SWOT Analysis
  10.2.6 Abbott Recent Developments
10.3 Siemens Healthineers
  10.3.1 Siemens Healthineers Basic Information
  10.3.2 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product Overview
  10.3.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.3.4 Siemens Healthineers Business Overview
  10.3.5 Siemens Healthineers SWOT Analysis
  10.3.6 Siemens Healthineers Recent Developments
10.4 DiaSorin
  10.4.1 DiaSorin Basic Information
  10.4.2 DiaSorin Prostate Specific Antigen (PSA) Testing Product Overview
  10.4.3 DiaSorin Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.4.4 DiaSorin Business Overview
  10.4.5 DiaSorin Recent Developments
10.5 Roche Holding AG
  10.5.1 Roche Holding AG Basic Information
  10.5.2 Roche Holding AG Prostate Specific Antigen (PSA) Testing Product Overview
  10.5.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.5.4 Roche Holding AG Business Overview
  10.5.5 Roche Holding AG Recent Developments
10.6 Beckman Coulter
  10.6.1 Beckman Coulter Basic Information
  10.6.2 Beckman Coulter Prostate Specific Antigen (PSA) Testing Product Overview
  10.6.3 Beckman Coulter Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.6.4 Beckman Coulter Business Overview
  10.6.5 Beckman Coulter Recent Developments
10.7 Mediwatch(LABORIE)
  10.7.1 Mediwatch(LABORIE) Basic Information
  10.7.2 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product Overview
  10.7.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.7.4 Mediwatch(LABORIE) Business Overview
  10.7.5 Mediwatch(LABORIE) Recent Developments
10.8 Boditech
  10.8.1 Boditech Basic Information
  10.8.2 Boditech Prostate Specific Antigen (PSA) Testing Product Overview
  10.8.3 Boditech Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.8.4 Boditech Business Overview
  10.8.5 Boditech Recent Developments
10.9 Bristol Myers Squibb
  10.9.1 Bristol Myers Squibb Basic Information
  10.9.2 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product Overview
  10.9.3 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.9.4 Bristol Myers Squibb Business Overview
  10.9.5 Bristol Myers Squibb Recent Developments
10.10 GE Healthcare
  10.10.1 GE Healthcare Basic Information
  10.10.2 GE Healthcare Prostate Specific Antigen (PSA) Testing Product Overview
  10.10.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.10.4 GE Healthcare Business Overview
  10.10.5 GE Healthcare Recent Developments
10.11 Endocare
  10.11.1 Endocare Basic Information
  10.11.2 Endocare Prostate Specific Antigen (PSA) Testing Product Overview
  10.11.3 Endocare Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.11.4 Endocare Business Overview
  10.11.5 Endocare Recent Developments
10.12 GlaxoSmith Kline
  10.12.1 GlaxoSmith Kline Basic Information
  10.12.2 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product Overview
  10.12.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.12.4 GlaxoSmith Kline Business Overview
  10.12.5 GlaxoSmith Kline Recent Developments
10.13 Anixa Biosciences
  10.13.1 Anixa Biosciences Basic Information
  10.13.2 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product Overview
  10.13.3 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.13.4 Anixa Biosciences Business Overview
  10.13.5 Anixa Biosciences Recent Developments
10.14 Ortho Clinical
  10.14.1 Ortho Clinical Basic Information
  10.14.2 Ortho Clinical Prostate Specific Antigen (PSA) Testing Product Overview
  10.14.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.14.4 Ortho Clinical Business Overview
  10.14.5 Ortho Clinical Recent Developments
10.15 Fujirebio
  10.15.1 Fujirebio Basic Information
  10.15.2 Fujirebio Prostate Specific Antigen (PSA) Testing Product Overview
  10.15.3 Fujirebio Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.15.4 Fujirebio Business Overview
  10.15.5 Fujirebio Recent Developments
10.16 Merck
  10.16.1 Merck Basic Information
  10.16.2 Merck Prostate Specific Antigen (PSA) Testing Product Overview
  10.16.3 Merck Prostate Specific Antigen (PSA) Testing Product Market Performance
  10.16.4 Merck Business Overview
  10.16.5 Merck Recent Developments

11 PROSTATE SPECIFIC ANTIGEN (PSA) TESTING MARKET FORECAST BY REGION

11.1 Global Prostate Specific Antigen (PSA) Testing Market Size Forecast
11.2 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Prostate Specific Antigen (PSA) Testing Market Size Forecast by Country
  11.2.3 Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size Forecast by Region
  11.2.4 South America Prostate Specific Antigen (PSA) Testing Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Prostate Specific Antigen (PSA) Testing by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Prostate Specific Antigen (PSA) Testing by Type (2026-2035)
  12.1.2 Global Prostate Specific Antigen (PSA) Testing Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Prostate Specific Antigen (PSA) Testing by Type (2026-2035)
12.2 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Application (2026-2035)
  12.2.1 Global Prostate Specific Antigen (PSA) Testing Sales (K Units) Forecast by Application
  12.2.2 Global Prostate Specific Antigen (PSA) Testing Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Prostate Specific Antigen (PSA) Testing Market Size by Type (M USD)
Table 4. Global Prostate Specific Antigen (PSA) Testing Market Size by Application
Table 5. Prostate Specific Antigen (PSA) Testing Market Size Comparison by Region (M USD)
Table 6. Global Prostate Specific Antigen (PSA) Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Prostate Specific Antigen (PSA) Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Prostate Specific Antigen (PSA) Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Prostate Specific Antigen (PSA) Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Testing as of 2025)
Table 11. Global Market Prostate Specific Antigen (PSA) Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Prostate Specific Antigen (PSA) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prostate Specific Antigen (PSA) Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Prostate Specific Antigen (PSA) Testing Sales by Type (K Units)
Table 27. Global Prostate Specific Antigen (PSA) Testing Market Size by Type (M USD)
Table 28. Global Prostate Specific Antigen (PSA) Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Prostate Specific Antigen (PSA) Testing Sales Market Share by Type (2020-2025)
Table 30. Global Prostate Specific Antigen (PSA) Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Prostate Specific Antigen (PSA) Testing Market Share by Type (2020-2025)
Table 32. Global Prostate Specific Antigen (PSA) Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Prostate Specific Antigen (PSA) Testing Sales (K Units) by Application
Table 34. Global Prostate Specific Antigen (PSA) Testing Market Size by Application
Table 35. Global Prostate Specific Antigen (PSA) Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Prostate Specific Antigen (PSA) Testing Sales Market Share by Application (2020-2025)
Table 37. Global Prostate Specific Antigen (PSA) Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Prostate Specific Antigen (PSA) Testing Market Share by Application (2020-2025)
Table 39. Global Prostate Specific Antigen (PSA) Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Prostate Specific Antigen (PSA) Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Prostate Specific Antigen (PSA) Testing Sales Market Share by Region (2020-2025)
Table 42. Global Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025)
Table 44. North America Prostate Specific Antigen (PSA) Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Prostate Specific Antigen (PSA) Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Prostate Specific Antigen (PSA) Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Prostate Specific Antigen (PSA) Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Prostate Specific Antigen (PSA) Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Prostate Specific Antigen (PSA) Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Prostate Specific Antigen (PSA) Testing Production (K Units) by Region(2020-2025)
Table 55. Global Prostate Specific Antigen (PSA) Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Prostate Specific Antigen (PSA) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Prostate Specific Antigen (PSA) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Prostate Specific Antigen (PSA) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Prostate Specific Antigen (PSA) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Prostate Specific Antigen (PSA) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Cleveland Diagnostics Basic Information
Table 63. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product Overview
Table 64. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Cleveland Diagnostics Business Overview
Table 66. Cleveland Diagnostics SWOT Analysis
Table 67. Cleveland Diagnostics Recent Developments
Table 68. Abbott Basic Information
Table 69. Abbott Prostate Specific Antigen (PSA) Testing Product Overview
Table 70. Abbott Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Abbott Business Overview
Table 72. Abbott SWOT Analysis
Table 73. Abbott Recent Developments
Table 74. Siemens Healthineers Basic Information
Table 75. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product Overview
Table 76. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Siemens Healthineers Business Overview
Table 78. Siemens Healthineers SWOT Analysis
Table 79. Siemens Healthineers Recent Developments
Table 80. DiaSorin Basic Information
Table 81. DiaSorin Prostate Specific Antigen (PSA) Testing Product Overview
Table 82. DiaSorin Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. DiaSorin Business Overview
Table 84. DiaSorin Recent Developments
Table 85. Roche Holding AG Basic Information
Table 86. Roche Holding AG Prostate Specific Antigen (PSA) Testing Product Overview
Table 87. Roche Holding AG Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Roche Holding AG Business Overview
Table 89. Roche Holding AG Recent Developments
Table 90. Beckman Coulter Basic Information
Table 91. Beckman Coulter Prostate Specific Antigen (PSA) Testing Product Overview
Table 92. Beckman Coulter Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Beckman Coulter Business Overview
Table 94. Beckman Coulter Recent Developments
Table 95. Mediwatch(LABORIE) Basic Information
Table 96. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product Overview
Table 97. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Mediwatch(LABORIE) Business Overview
Table 99. Mediwatch(LABORIE) Recent Developments
Table 100. Boditech Basic Information
Table 101. Boditech Prostate Specific Antigen (PSA) Testing Product Overview
Table 102. Boditech Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Boditech Business Overview
Table 104. Boditech Recent Developments
Table 105. Bristol Myers Squibb Basic Information
Table 106. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product Overview
Table 107. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Bristol Myers Squibb Business Overview
Table 109. Bristol Myers Squibb Recent Developments
Table 110. GE Healthcare Basic Information
Table 111. GE Healthcare Prostate Specific Antigen (PSA) Testing Product Overview
Table 112. GE Healthcare Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. GE Healthcare Business Overview
Table 114. GE Healthcare Recent Developments
Table 115. Endocare Basic Information
Table 116. Endocare Prostate Specific Antigen (PSA) Testing Product Overview
Table 117. Endocare Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Endocare Business Overview
Table 119. Endocare Recent Developments
Table 120. GlaxoSmith Kline Basic Information
Table 121. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product Overview
Table 122. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. GlaxoSmith Kline Business Overview
Table 124. GlaxoSmith Kline Recent Developments
Table 125. Anixa Biosciences Basic Information
Table 126. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product Overview
Table 127. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Anixa Biosciences Business Overview
Table 129. Anixa Biosciences Recent Developments
Table 130. Ortho Clinical Basic Information
Table 131. Ortho Clinical Prostate Specific Antigen (PSA) Testing Product Overview
Table 132. Ortho Clinical Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Ortho Clinical Business Overview
Table 134. Ortho Clinical Recent Developments
Table 135. Fujirebio Basic Information
Table 136. Fujirebio Prostate Specific Antigen (PSA) Testing Product Overview
Table 137. Fujirebio Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Fujirebio Business Overview
Table 139. Fujirebio Recent Developments
Table 140. Merck Basic Information
Table 141. Merck Prostate Specific Antigen (PSA) Testing Product Overview
Table 142. Merck Prostate Specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Merck Business Overview
Table 144. Merck Recent Developments
Table 145. Global Prostate Specific Antigen (PSA) Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Prostate Specific Antigen (PSA) Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Prostate Specific Antigen (PSA) Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Prostate Specific Antigen (PSA) Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Prostate Specific Antigen (PSA) Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Prostate Specific Antigen (PSA) Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Prostate Specific Antigen (PSA) Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Prostate Specific Antigen (PSA) Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Prostate Specific Antigen (PSA) Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Prostate Specific Antigen (PSA) Testing Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Prostate Specific Antigen (PSA) Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Prostate Specific Antigen (PSA) Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Prostate Specific Antigen (PSA) Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Prostate Specific Antigen (PSA) Testing Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Prostate Specific Antigen (PSA) Testing Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Prostate Specific Antigen (PSA) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prostate Specific Antigen (PSA) Testing Market Size (M USD), 2025-2035
Figure 5. Global Prostate Specific Antigen (PSA) Testing Market Size (M USD) (2020-2035)
Figure 6. Global Prostate Specific Antigen (PSA) Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prostate Specific Antigen (PSA) Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Prostate Specific Antigen (PSA) Testing Product Life Cycle
Figure 13. Prostate Specific Antigen (PSA) Testing Sales Share by Manufacturers in 2025
Figure 14. Global Prostate Specific Antigen (PSA) Testing Revenue Share by Manufacturers in 2025
Figure 15. Prostate Specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Prostate Specific Antigen (PSA) Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Prostate Specific Antigen (PSA) Testing Revenue in 2025
Figure 18. Industry Chain Map of Prostate Specific Antigen (PSA) Testing
Figure 19. Global Prostate Specific Antigen (PSA) Testing Market PEST Analysis
Figure 20. Global Prostate Specific Antigen (PSA) Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Prostate Specific Antigen (PSA) Testing Market Share by Type
Figure 27. Sales Market Share of Prostate Specific Antigen (PSA) Testing by Type (2020-2025)
Figure 28. Sales Market Share of Prostate Specific Antigen (PSA) Testing by Type in 2025
Figure 29. Market Share of Prostate Specific Antigen (PSA) Testing by Type (2020-2025)
Figure 30. Market Share of Prostate Specific Antigen (PSA) Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Prostate Specific Antigen (PSA) Testing Market Share by Application
Figure 33. Global Prostate Specific Antigen (PSA) Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Prostate Specific Antigen (PSA) Testing Sales Market Share by Application in 2025
Figure 35. Global Prostate Specific Antigen (PSA) Testing Market Share by Application (2020-2025)
Figure 36. Global Prostate Specific Antigen (PSA) Testing Market Share by Application in 2025
Figure 37. Global Prostate Specific Antigen (PSA) Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Prostate Specific Antigen (PSA) Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Prostate Specific Antigen (PSA) Testing Market Size by Region (2020-2025)
Figure 40. North America Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Prostate Specific Antigen (PSA) Testing Sales Market Share by Country in 2024
Figure 43. North America Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Prostate Specific Antigen (PSA) Testing Market Size by Country in 2024
Figure 45. U.S. Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Prostate Specific Antigen (PSA) Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Prostate Specific Antigen (PSA) Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Prostate Specific Antigen (PSA) Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Prostate Specific Antigen (PSA) Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Prostate Specific Antigen (PSA) Testing Sales Market Share by Country in 2024
Figure 53. Europe Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Prostate Specific Antigen (PSA) Testing Market Size by Country in 2024
Figure 55. Germany Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Prostate Specific Antigen (PSA) Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region in 2024
Figure 68. China Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (K Units)
Figure 79. South America Prostate Specific Antigen (PSA) Testing Sales Market Share by Country in 2024
Figure 80. South America Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (M USD)
Figure 81. South America Prostate Specific Antigen (PSA) Testing Market Size by Country in 2024
Figure 82. Brazil Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Prostate Specific Antigen (PSA) Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Prostate Specific Antigen (PSA) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Prostate Specific Antigen (PSA) Testing Production Market Share by Region (2020-2025)
Figure 103. North America Prostate Specific Antigen (PSA) Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Prostate Specific Antigen (PSA) Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Prostate Specific Antigen (PSA) Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Prostate Specific Antigen (PSA) Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Prostate Specific Antigen (PSA) Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Prostate Specific Antigen (PSA) Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Prostate Specific Antigen (PSA) Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Prostate Specific Antigen (PSA) Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Prostate Specific Antigen (PSA) Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Prostate Specific Antigen (PSA) Testing Market Share Forecast by Application (2026-2035)